GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Decision Diagnostics Corp (OTCPK:DECN) » Definitions » EV-to-EBIT

Decision Diagnostics (Decision Diagnostics) EV-to-EBIT : 0.00 (As of Apr. 26, 2024)


View and export this data going back to . Start your Free Trial

What is Decision Diagnostics EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Decision Diagnostics's Enterprise Value is $0.00 Mil. Decision Diagnostics's EBIT for the trailing twelve months (TTM) ended in Sep. 2021 was $-2.06 Mil. Therefore, Decision Diagnostics's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Decision Diagnostics's EV-to-EBIT or its related term are showing as below:

DECN's EV-to-EBIT is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 18.61
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Decision Diagnostics's Enterprise Value for the quarter that ended in Sep. 2021 was $3.14 Mil. Decision Diagnostics's EBIT for the trailing twelve months (TTM) ended in Sep. 2021 was $-2.06 Mil. Decision Diagnostics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2021 was -65.77%.


Decision Diagnostics EV-to-EBIT Historical Data

The historical data trend for Decision Diagnostics's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decision Diagnostics EV-to-EBIT Chart

Decision Diagnostics Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec17 Dec18 Dec19 Dec20
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.03 -3.15 -1.98 -36.60 -3.62

Decision Diagnostics Quarterly Data
Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.24 -3.62 -4.61 -3.51 -1.52

Competitive Comparison of Decision Diagnostics's EV-to-EBIT

For the Pharmaceutical Retailers subindustry, Decision Diagnostics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Decision Diagnostics's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Decision Diagnostics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Decision Diagnostics's EV-to-EBIT falls into.



Decision Diagnostics EV-to-EBIT Calculation

Decision Diagnostics's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/-2.062
=0.00

Decision Diagnostics's current Enterprise Value is $0.00 Mil.
Decision Diagnostics's EBIT for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Decision Diagnostics  (OTCPK:DECN) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Decision Diagnostics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2021 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2021 ) =EBIT / Enterprise Value (Q: Sep. 2021 )
=-2.062/3.1353613
=-65.77 %

Decision Diagnostics's Enterprise Value for the quarter that ended in Sep. 2021 was $3.14 Mil.
Decision Diagnostics's EBIT for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Decision Diagnostics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Decision Diagnostics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Decision Diagnostics (Decision Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
2660 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361
Decision Diagnostics Corp is a provider of prescription drugs, home testing products for the chronically ill, direct to patient diabetes programs, and a developer of revolutionary, cell phone centric, e-health products and technology. The company also provides blood glucose home testing test strips and exciting new concepts for blood testing monitors.
Executives
Keith Berman director, officer: Secretary 2660 TOWNSGATE RD #300, WESTLAKE VILLAGE CA 91361
Robert Jagunich director 765 CHRISTINE DR PALO ALTO CA 94303
Robert Lawrence Cox director, officer: President

Decision Diagnostics (Decision Diagnostics) Headlines

From GuruFocus